United States · FDA National Drug Code directory
Lisinopril and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-2565_0cdef2de-f08e-4c51-ba5f-1be5e32d6dd8
- Product NDC
- 50090-2565
- Form
- TABLET
- Composition / generic term
- Lisinopril and Hydrochlorothiazide
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20061004
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
- LISINOPRIL — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (50090-2565-0) · 50090-2565-0
- 90 TABLET in 1 BOTTLE (50090-2565-1) · 50090-2565-1
- 100 TABLET in 1 BOTTLE (50090-2565-2) · 50090-2565-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →